miR-21, miR-99b and miR-375 combination as predictive response signature for preoperative chemoradiotherapy in rectal cancer
Fig 2
(A) ROC curve analyses to evaluate the potential utility of miR-21, miR-99b, miR-375 and their combination to distinguish patients with maximum response to neoadjuvant treatment (TRG4) from others. (B) ROC curve analysis comparing the miRNA combination with pre-CRT clinical stage and CEA levels.